According to new data, researchers found that repeat dosing of @Capricor Therapeutics’ CAP-1002 results in increased exercise performance in a disease model of Duchenne muscular dystrophy, the mdx mouse.

Leadership lessons we can all learn from Tammie Jo Shults:

$GWPH gets unanimous 13-0 vote from outside panel of advisers to FDA that benefit-risk profile of Epidiolex is favorable for treatment of childhood epilepsies

#Retail management and point-of-sale platform raised $17M Series A #funding round

Curious what the athletic director at your favorite university takes home? Well wonder no more!

Load More...